|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.250 USD | -2.82% |
|
-0.41% | +3.57% |
| 04:10am | Teladoc Health, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 03:45 PM | |
| 01-12 | Teladoc Health, Inc. Launches Enhanced 24/7 Care Service | CI |
| Capitalization | 1.29B 1.1B 1.02B 955M 1.78B 116B 1.91B 11.8B 4.64B 55.48B 4.83B 4.73B 203B | P/E ratio 2025 * |
-6.24x | P/E ratio 2026 * | -9.4x |
|---|---|---|---|---|---|
| Enterprise value | 1.63B 1.4B 1.3B 1.21B 2.27B 147B 2.43B 15B 5.9B 70.49B 6.13B 6.01B 258B | EV / Sales 2025 * |
0.65x | EV / Sales 2026 * | 0.59x |
| Free-Float |
99.19% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Teladoc Health, Inc.
| 1 day | +0.28% | ||
| 1 week | -0.41% | ||
| Current month | +3.57% | ||
| 1 month | -3.97% | ||
| 3 months | -9.38% | ||
| 6 months | -12.86% | ||
| Current year | +3.57% |
| 1 week | 7.22 |  | 8.06 |
| 1 month | 6.88 | | 8.06 |
| Current year | 6.94 | | 8.06 |
| 1 year | 6.35 | | 15.21 |
| 3 years | 6.35 | | 34.36 |
| 5 years | 6.35 | | 308 |
| 10 years | 6.35 | | 308 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Divita
CEO | Chief Executive Officer | 56 | 10/06/2024 |
Nikolaos Nanis
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jeff Nadler
CTO | Chief Tech/Sci/R&D Officer | - | 02/02/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Tom McKinley
BRD | Director/Board Member | 74 | 01/11/2009 |
David Snow
CHM | Chairman | 71 | 01/12/2014 |
David Shedlarz
BRD | Director/Board Member | 76 | 19/09/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.82% | -0.41% | -26.55% | -72.15% | 1.29B | |
| +2.05% | -6.83% | +27.27% | +355.49% | 7.36B | |
| +4.61% | +7.40% | - | - | 933M | |
| -0.75% | +9.62% | +36.64% | +439.33% | 661M | |
| -0.60% | +5.37% | -36.86% | +1,404.36% | 659M | |
| -4.06% | -4.80% | -31.30% | -93.54% | 81.2M | |
| -1.79% | -6.78% | -59.56% | -92.14% | 52.12M | |
| Average | -0.16% | -0.01% | -15.06% | +323.56% | 1.58B | |
| Weighted average by Cap. | +0.89% | -3.46% | +15.93% | +368.98% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.52B 2.16B 2.01B 1.87B 3.5B 227B 3.75B 23.15B 9.1B 109B 9.46B 9.27B 399B | 2.55B 2.18B 2.03B 1.89B 3.54B 230B 3.79B 23.38B 9.19B 110B 9.56B 9.36B 403B |
| Net income | -207M -177M -164M -153M -287M -18.62B -307M -1.89B -745M -8.91B -775M -759M -32.65B | -143M -123M -114M -106M -199M -12.93B -213M -1.32B -517M -6.18B -538M -527M -22.67B |
| Net Debt | 348M 298M 277M 259M 483M 31.38B 518M 3.19B 1.26B 15.01B 1.31B 1.28B 55.05B | 221M 189M 176M 164M 306M 19.88B 328M 2.02B 795M 9.51B 827M 810M 34.87B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/01/26 | 7.250 $ | -2.82% | 3,679,232 |
| 09/01/26 | 7.460 $ | -1.97% | 4,997,438 |
| 08/01/26 | 7.610 $ | +0.53% | 4,501,479 |
| 07/01/26 | 7.570 $ | -5.37% | 4,770,869 |
| 06/01/26 | 8.000 $ | +9.89% | 9,269,362 |
Delayed Quote Nyse, January 13, 2026 at 12:00 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TDOC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition